Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH)
暂无分享,去创建一个
J. G. Hengstler | W. Lilienblum | W. Dekant | H. Foth | T. Gebel | R. Kahl | P.-J. Kramer | H. Schweinfurth | K.-M. Wollin | J. Hengstler | W. Dekant | K. Wollin | T. Gebel | P. Kramer | H. Foth | R. Kahl | H. Schweinfurth | W. Lilienblum
[1] S Coecke,et al. Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.
[2] Gunnar Johanson,et al. Uptake and disposition of inhaled methanol vapor in humans. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[3] Raffaella Corvi,et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.
[4] J C Madden,et al. Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier , 2007, SAR and QSAR in environmental research.
[5] Sharon Munn,et al. Assessment of additional testing needs under REACH Effects of (Q)SARS, risk based testing and voluntary industry initiatives , 2003 .
[6] Robert Combes,et al. Intelligent Testing Strategies for Chemicals Testing — A Case of More Haste, Less Speed? , 2005, Alternatives to laboratory animals : ATLA.
[7] Anna Forsby,et al. Blood-Brain Barrier In Vitro Models and Their Application in Toxicology: The Report and Recommendations of ECVAM Workshop 491,2 , 2004, Alternatives to laboratory animals : ATLA.
[8] Horst Spielmann,et al. Currently available in vitro methods used in the regulatory toxicology. , 2002, Toxicology letters.
[9] Jan G Hengstler,et al. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. , 2004, Toxicology letters.
[10] Nancy G Doerrer,et al. A tiered approach to life stages testing for agricultural chemical safety assessment. , 2007, Critical reviews in toxicology.
[11] H. Ellinger-Ziegelbauer,et al. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. , 2005, Mutation research.
[12] Noriho Tanaka,et al. An assay method for the prediction of tumor promoting potential of chemicals by the use of Bhas 42 cells. , 2004, Mutation research.
[13] Andrew Worth,et al. ECVAM's Response to the Changing Political Environment for Alternatives: Consequences of the European Union Chemicals and Cosmetics Policies , 2003, Alternatives to laboratory animals : ATLA.
[14] Aldert H Piersma,et al. Alternative methods for developmental toxicity testing. , 2006, Basic & clinical pharmacology & toxicology.
[15] I Gerner,et al. Development of a Decision Support System for the Introduction of Alternative Methods into Local Irritancy/Corrosivity Testing Strategies. Creation of Fundamental Rules for a Decision Support System , 2000, Alternatives to laboratory animals : ATLA.
[16] Aldert H Piersma,et al. Validation of the Postimplantation Rat Whole-embryo Culture Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.
[17] M. Dent,et al. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility. , 2007, Regulatory toxicology and pharmacology : RTP.
[18] H M Bolt,et al. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. , 2003, Annual review of pharmacology and toxicology.
[19] Hideki Miyaura,et al. Differences in gene expression profiles in the liver between carcinogenic and non-carcinogenic isomers of compounds given to rats in a 28-day repeat-dose toxicity study. , 2006, Toxicology and applied pharmacology.
[20] Helmut Greim,et al. Toxicological comments to the discussion about REACH , 2006, Archives of Toxicology.
[21] Horst Spielmann,et al. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation , 2004, Archives of Toxicology.
[22] Xidong Jin,et al. Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. , 2004, Mutation research.
[23] L. Ehrenberg,et al. Pharmacokinetics of ethylene in man; body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene , 2005, Archives of Toxicology.
[24] N. Z. Zur Nieden,et al. Molecular multiple endpoint embryonic stem cell test--a possible approach to test for the teratogenic potential of compounds. , 2004, Toxicology and applied pharmacology.
[25] Hannu Raunio,et al. Prediction of drug metabolism and interactions on the basis of in vitro investigations. , 2005, Basic & clinical pharmacology & toxicology.
[26] Anna Forsby,et al. Blood – Brain Barrier In Vitro Models and Their Application in Toxicology The Report and Recommendations of ECVAM Workshop , 2004 .
[27] Eun-Mi Kim,et al. Gene expression profiling in lung tissues from rats exposed to formaldehyde , 2007, Archives of Toxicology.
[28] Silvia Casati,et al. Strategies to Replace in Vivo Acute Systemic Toxicity Testing: The Report and Recommendations of ECVAM Workshop 501,2 , 2004, Alternatives to laboratory animals : ATLA.
[29] Valérie Zuang,et al. Dendritic Cells as a Tool for the Predictive Identification of Skin Sensitisation Hazard , 2005, Alternatives to laboratory animals : ATLA.
[30] Thomas Hartung,et al. The value of alternative testing for neurotoxicity in the context of regulatory needs. , 2006, Environmental toxicology and pharmacology.
[31] Sir,et al. Selected Integrated Testing Strategies (ITS) for the risk assessment of chemicals , 2007 .
[32] J. Hengstler,et al. The REACH concept and its impact on toxicological sciences. , 2006, Toxicology.
[33] Pamela Lein,et al. Meeting Report: Alternatives for Developmental Neurotoxicity Testing , 2007, Environmental health perspectives.
[34] Noriho Tanaka,et al. Use of a Cell Transformation Assay with Established Cell Lines, and a Metabolic Cooperation Assay with V79 Cells for the Detection of Tumour Promoters: A Review , 2002, Alternatives to laboratory animals : ATLA.
[35] T. Hartung,et al. Making Validated Alternatives Available -the Strategies and Work of the European Centre for the Validation of Alternative Methods (ECVAM) , 2005 .
[36] Alexius Freyberger,et al. The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration , 2007, Archives of Toxicology.
[37] R. Kroes. Structure-Based Thresholds of Toxicological Concern (TTC): Guidance for Application to Substances Present at Low Levels in the Diet , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[38] Gunnar Johanson,et al. Toxicokinetics of 1,1,1,2-tetrafluoroethane (HFC-134a) in male volunteers after experimental exposure. , 2006, Toxicology letters.
[39] John D. Walker,et al. (Q)SARs for predicting skin irritation and corrosion: Mechanisms, transparency and applicability of predictions , 2004 .
[40] A G Renwick,et al. Structure-based thresholds of toxicological concern--guidance for application to substances present at low levels in the diet. , 2005, Toxicology and applied pharmacology.
[41] J. V. van Delft,et al. In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. , 2007, Toxicology and applied pharmacology.
[42] Balls Michael. Alternatives to Animal Experiments. , 2001 .
[43] Melvin E Andersen,et al. Toxicokinetic modeling and its applications in chemical risk assessment. , 2003, Toxicology letters.
[44] I Gerner,et al. Chemical substances and contact allergy--244 substances ranked according to allergenic potency. , 2003, Toxicology.
[45] George Daston,et al. The Effects of Chemicals on Mammalian Fertility , 2005, Alternatives to laboratory animals : ATLA.
[46] R G Ulrich,et al. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. , 2001, Toxicology and applied pharmacology.
[47] Thomas Hartung,et al. Meeting Report: Validation of Toxicogenomics-Based Test Systems: ECVAM–ICCVAM/NICEATM Considerations for Regulatory Use , 2005, Environmental health perspectives.
[48] U. Tillmann,et al. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.
[49] John D. Walker,et al. Use of structural alerts to develop rules for identifying chemical substances with skin irritation or skin corrosion potential , 2005 .
[50] F. Williams,et al. EDETOX. Evaluations and predictions of dermal absorption of toxic chemicals , 2004, International archives of occupational and environmental health.
[51] Andrew Worth,et al. Metabolism: A Bottleneck in In Vitro Toxicological Test Development , 2006, Alternatives to laboratory animals : ATLA.
[52] Munn Sharon j.,et al. Alternative Approaches Can Reduce the Use of Test Animals under REACH. , 2004 .
[53] Wolfgang Völkel,et al. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. , 2002, Chemical research in toxicology.
[54] Coecke Sandra,et al. Validation of Toxicogenomics-Based Test Systems:ECVAM-ICCVAM/NICEATM Considerations for Regulatory Use , 2006 .
[55] T Hartung,et al. The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development. , 2004, Current pharmaceutical design.
[56] A P Worth,et al. The Importance of the Prediction Model in the Validation of Alternative Tests , 2001, Alternatives to laboratory animals : ATLA.
[57] P. Botham,et al. Acute systemic toxicity--prospects for tiered testing strategies. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.
[58] Robert Combes,et al. Why ‘Suitable’ In Vitro Methods, as Defined in the Final EU REACH Legislation, are an Inappropriate Basis for Risk Assessment , 2007, Alternatives to laboratory animals : ATLA.
[59] Ulrike Bernauer,et al. The use of in vitro data in risk assessment. , 2005, Basic & clinical pharmacology & toxicology.
[60] Jan G. Hengstler,et al. ERBB2-Mediated Transcriptional Up-regulation of the α5β1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions , 2006 .
[61] Johannes J M van de Sandt,et al. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. , 2006, Toxicology letters.
[62] Petra S Kern,et al. TIMES-SS--a promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q)SARs and an external evaluation for predictivity. , 2007, Regulatory toxicology and pharmacology : RTP.
[63] Valérie Zuang,et al. The Principles of Weight of Evidence Validation of Test Methods and Testing Strategies , 2006, Alternatives to laboratory animals : ATLA.
[64] Aldert Piersma,et al. The Practical Application of Three Validated In Vitro Embryotoxicity Tests , 2006, Alternatives to laboratory animals : ATLA.
[65] W. Russell,et al. Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.
[66] Michael Balls,et al. The principles of validation and the ECVAM validation process. , 2002, Alternatives to laboratory animals : ATLA.
[67] Thomas Steger-Hartmann,et al. Use of computer-assisted prediction of toxic effects of chemical substances. , 2006, Toxicology.
[68] Zuang Valerie,et al. The Principles of Weight of Evidence Validation of Test Methods and Testing Strategies , 2006 .
[69] Thomas Hartung,et al. Developmental toxicity testing from animal towards embryonic stem cells. , 2005, ALTEX.
[70] C. Schlatter,et al. Pharmacokinetics of 2,3,7,8-TCDD in man , 1986 .
[71] Kayo Sumida,et al. Analysis of gene expression profiles of forestomach tumors in rasH2 mice initiated with N-ethyl-N-nitrosourea , 2004, Archives of Toxicology.
[72] F. Oesch,et al. New Hepatocyte In Vitro Systems for Drug Metabolism: Metabolic Capacity and Recommendations for Application in Basic Research and Drug Development, Standard Operation Procedures , 2003, Drug metabolism reviews.
[73] Inge Mangelsdorf,et al. Some aspects relating to the evaluation of the effects of chemicals on male fertility. , 2003, Regulatory toxicology and pharmacology : RTP.
[74] F. Oesch,et al. CRYOPRESERVED PRIMARY HEPATOCYTES AS A CONSTANTLY AVAILABLE IN VITRO MODEL FOR THE EVALUATION OF HUMAN AND ANIMAL DRUG METABOLISM AND ENZYME INDUCTION* , 2000, Drug metabolism reviews.
[75] Robert Combes,et al. An Overall Strategy for the Testing of Chemicals for Human Hazard and Risk Assessment under the EU REACH System , 2003, Alternatives to laboratory animals : ATLA.
[76] Miho Nagai,et al. An Interlaboratory Collaborative Study on a Cell Transformation Assay Using Bhas 42 Cells , 2009 .
[77] Anna Forsby,et al. Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity , 2007, Human & experimental toxicology.
[78] Y Ohno,et al. Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats--overview of the studies. , 2000, The Journal of toxicological sciences.
[79] Ulrike Bernauer,et al. Biotransformation of trichloroethene: dose-dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation , 1996, Archives of Toxicology.
[80] Valérie Zuang,et al. A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.
[81] Raffaella Corvi,et al. The Assessment of Repeated Dose Toxicity In Vitro: A Proposed Approach , 2006, Alternatives to laboratory animals : ATLA.
[82] W. Dekant,et al. Toxicokinetics of methyl tert-butyl ether and its metabolites in humans after oral exposure. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[83] Melvin E. Andersen,et al. The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative , 2006, Archives of Toxicology.
[84] John D. Walker,et al. The Skin Irritation Corrosion Rules Estimation Tool (SICRET) , 2005 .
[85] B J Blaauboer,et al. An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing. , 2005, Regulatory toxicology and pharmacology : RTP.
[86] W. Dekant,et al. Dose-dependent protein adduct formation in kidney, liver, and blood of rats and in human blood after perchloroethene inhalation. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[87] T. Fennell,et al. Metabolism and hemoglobin adduct formation of acrylamide in humans. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[88] Jan G Hengstler,et al. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells. , 2005, Cancer research.
[89] Hayley S. Brown,et al. Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.
[90] G Patlewicz,et al. Global (Q)SARs for skin sensitisation–assessment against OECD principles , 2007, SAR and QSAR in environmental research.
[91] H. Ellinger-Ziegelbauer,et al. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. , 2008, Mutation research.
[92] Christel A. S. Bergström,et al. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. , 2005, Basic & clinical pharmacology & toxicology.
[93] N. Clemann,et al. The embryonic stem cell test for the early selection of pharmaceutical compounds. , 2007, ALTEX.
[94] Wolfgang Völkel,et al. Kinetics of 3-(4-methylbenzylidene)camphor in rats and humans after dermal application. , 2006, Toxicology and applied pharmacology.
[95] John D. Walker,et al. Use of Physicochemical Property Limits to Develop Rules for Identifying Chemical Substances with no Skin Irritation or Corrosion Potential , 2004 .
[96] Kiyoshi Sasaki,et al. Isolation and Characterization of ras‐Transfected BALB/3T3 Clone Showing Morphological Transformation by 12‐O‐Tetradecanoyl‐phorbol‐13‐acetate , 1988, Japanese journal of cancer research : Gann.
[97] Wout Slob,et al. A retrospective analysis of the two-generation study: what is the added value of the second generation? , 2007, Reproductive toxicology.
[98] Worth Andrew,et al. Alternative (Non-Animal) Methods for Chemicals Testing: Current Status and Future Prospects (A Report Prepared by ECVAM and the ECVAM WG on Chemicals) , 2002 .
[99] Aldert H Piersma,et al. Validation of the Rat Limb Bud Micromass Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.
[100] Michael Schwarz,et al. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. , 2005, Reproductive toxicology.
[101] David J Brayden,et al. In Vitro Models of the Intestinal Barrier , 2001, Alternatives to laboratory animals : ATLA.
[102] J. Haines,et al. International programme on chemical safety , 1996, The Lancet.
[103] Thomas Hartung,et al. Workgroup Report: Incorporating In Vitro Alternative Methods for Developmental Neurotoxicity into International Hazard and Risk Assessment Strategies , 2007, Environmental health perspectives.
[104] Bas J Blaauboer,et al. The Necessity of Biokinetic Information in the Interpretation of In Vitro Toxicity Data , 2002, Alternatives to laboratory animals : ATLA.
[105] Andrew Worth,et al. The Registry of Cytotoxicity: Toxicity Testing in Cell Cultures to Predict Acute Toxicity (LD50) and to Reduce Testing in Animals 1 , 2003, Alternatives to laboratory animals : ATLA.
[106] William Stokes. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): Recent Progress in the Evaluation of Alternative Toxicity Testing Methods , 2003 .
[107] Alison Abbott. Animal testing: More than a cosmetic change , 2005, Nature.
[108] William S Stokes,et al. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): Recent Progress in the Evaluation of Alternative Toxicity Testing Methods , 2003 .
[109] Susanne Bremer,et al. Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.
[110] Han van de Waterbeemd. Which in vitro screens guide the prediction of oral absorption and volume of distribution? , 2005, Basic & clinical pharmacology & toxicology.
[111] Katsuhiko Arai,et al. Gene expression analysis in mice liver on hepatocarcinogenesis by flumequine , 2006, Archives of Toxicology.
[112] Michael Balls,et al. The Principles of Validation and the ECVAM Validation Process , 2002, Alternatives to laboratory animals : ATLA.
[113] Roland Buesen,et al. Current status of the embryonic stem cell test: The use of recent advances in the field of stem cell technology and gene expression analysis , 2006 .
[114] Atsushi Ono,et al. Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators. , 2006, The Journal of toxicological sciences.
[115] Horst Spielmann,et al. Assessment of the Eye Irritating Properties of Chemicals by Applying Alternatives to the Draize Rabbit Eye Test: The Use of QSARs and In Vitro Tests for the Classification of Eye Irritation , 2005, Alternatives to laboratory animals : ATLA.
[116] Heidrun Ellinger-Ziegelbauer,et al. Establishment of a protocol for the gene expression analysis of laser microdissected rat kidney samples with affymetrix genechips. , 2006, Toxicology and applied pharmacology.
[117] F. Williams,et al. In vitro studies-how good are they at replacing in vivo studies for measurement of skin absorption? , 2006, Environmental toxicology and pharmacology.